Truist Financial’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,312
Closed -$793K 2771
2020
Q4
$793K Buy
6,312
+527
+9% +$58.9K ﹤0.01% 1611
2020
Q3
$587K Buy
5,785
+204
+4% +$20.8K ﹤0.01% 1639
2020
Q2
$542K Sell
5,581
-1,358
-20% -$126K ﹤0.01% 1577
2020
Q1
$576K Sell
6,939
-1,339
-16% -$131K ﹤0.01% 1504
2019
Q4
$920K Buy
+8,278
New +$852K ﹤0.01% 1487

Other funds holding PRAH

Truist Financial's PRAH Position: Q1 2021 in Review

Truist Financial sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 6,312 shares — an estimated $793K sold.

Truist Financial first reported a position in PRAH in Q4 2019 and held it in 5 quarters. The position peaked at $920K in Q4 2019. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Truist Financial reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Truist Financial sold 6,312 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $793K.
  • Truist Financial first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 5 quarters.
  • Truist Financial's PRA Health Sciences, Inc. position peaked at $920K in Q4 2019.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Truist Financial's 13F filing for Q1 2021, filed 17 May 2021.